检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Gilles Jadd Hoilat Fathima Keshia Suhail Talal Adhami Savio John
机构地区:[1]Department of Medicine,SUNY Upstate Medical University,Syracuse,NY 13210,United States [2]Department of Gastroenterology,Cleveland Clinic Foundation,Cleveland,OH 44195,United States [3]Department of Gastroenterology,SUNY Upstate Medical University,Syracuse,NY 13210,United States
出 处:《World Journal of Hepatology》2022年第4期670-681,共12页世界肝病学杂志(英文版)(电子版)
摘 要:Hepatic encephalopathy(HE)is a reversible syndrome of impaired brain function and represents one of the many complications of portal hypertension and decompensated liver disease.Although ammonia is clearly implicated in the pathogenesis of HE,the pathogenesis of HE is multifactorial with numerous mechanisms that results in functional impairment of neuronal cells.The initial management of HE focuses on supportive care and stabilization which includes providing appropriate nutritional support.Thereafter,focus should be on identifying and treating the precipitating factors.There are many therapeutic agents available for the management of HE,most of which are directed towards lowering the gut nitrogen load and thus the serum ammonia level.This review aims to provide an update on the conventional and emerging treatment options for HE.
关 键 词:Hepatic encephalopathy LACTULOSE RIFAXIMIN Fecal microbiota transplant Zinc L-ornithine L-aspartate
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.171